Scientific Reports (Feb 2023)

Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-melanogenesis properties

  • Milad Noori,
  • Reyhaneh Sabourian,
  • Ali Tasharoie,
  • Maliheh Safavi,
  • Aida Iraji,
  • Minoo Khalili Ghomi,
  • Navid Dastyafteh,
  • Cambyz Irajie,
  • Elham Zarenezhad,
  • Seyyed Mehrdad Mostafavi Pour,
  • Fatemeh Rasekh,
  • Bagher Larijani,
  • Mohsen Amini,
  • Mannan Hajimahmoodi,
  • Mohammad Mahdavi

DOI
https://doi.org/10.1038/s41598-023-28852-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 17

Abstract

Read online

Abstract In the present study, a series of aryl-substituted thioqunoline conjugated to thiosemicarbazide were rationally designed and synthesized. The formation of target compounds was confirmed by spectral characterization techniques such as IR, 1H-NMR, 13C-NMR, ESI–MS, and elemental analysis. Among the synthesized derivatives, compound 10g bearing para-chlorophenyl moiety was proved to be the most potent tyrosinase inhibitor with an IC50 value of 25.75 ± 0.19 µM. Compound 10g as the most potent derivative exhibited a noncompetitive inhibition pattern against tyrosinase in the kinetic study. Furthermore, the in silico cavity detection, as well as the molecular docking assessments, were performed to follow the behavior of 10g within the proposed binding site. Besides, the toxicity of 10g and its potency to reduce the melanin content on A375 cell lines were also measured. Consequently, aryl-substituted thioqunolines conjugated to thiosemicarbazide might be a promising candidate in the cosmetics, medicine, and food industry as tyrosinase inhibitors.